| Primary adrenal lymphoma associated with adrenal insufficiency: a distinct clinical entity. | |
| | |
MedLine Citation:
|
PMID: 9156667 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We describe a case of a 42 year old male who presented with Addison's disease resulting from primary lymphoma of the adrenals. Our case and a review of the literature indicates that this distinct entity has some unique clinical and radiologic features. In this entity, the lymphoma tends to be extranodal and have a poor prognosis. In addition, the computed tomography (CT) images have the unique appearance of enlargement of the adrenal gland with maintenance of the adreniform shape. We suggest that primary adrenal lymphoma is a distinct clinical entity and should be considered in patients with an elevated serum lactate dehydrogenase, characteristic CT findings and Addison's disease. |
| | |
Authors:
|
M Pimentel; J B Johnston; D R Allan; H Greenberg; C N Bernstein |
Related Documents
:
|
15370127 - Diagnostic application of epstein-barr virus-encoded rna in situ hybridisation. 15160957 - Adrenal involvement in non-hodgkin's lymphoma: four cases and review of literature. 11994987 - Lymphoplasmacytoid lymphoma presenting as severe osteoporosis. 11478017 - Bilateral gynaecomastia as the primary complaint in hyperthyroidism. 3469227 - Fusarium as a pathogen. a case report of fusarium sepsis and review of the literature. 23053277 - Calcifying pseudoneoplasms of the neuraxis (capnon): clinical features and therapeutic ... |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: Leukemia & lymphoma Volume: 24 ISSN: 1042-8194 ISO Abbreviation: Leuk. Lymphoma Publication Date: 1997 Jan |
Date Detail:
|
Created Date: 1997-05-20 Completed Date: 1997-05-20 Revised Date: 2006-04-24 |
Medline Journal Info:
|
Nlm Unique ID: 9007422 Medline TA: Leuk Lymphoma Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 363-7 Citation Subset: IM |
Affiliation:
|
Department of Medicine, University of Manitoba, Winnipeg, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Addison Disease
/
blood,
etiology* Adrenal Cortex Neoplasms / blood, complications*, diagnosis, drug therapy, pathology Adrenal Gland Diseases / diagnosis Adult Antineoplastic Combined Chemotherapy Protocols / therapeutic use Cosyntropin / diagnostic use Cyclophosphamide / administration & dosage Dexamethasone / administration & dosage Diagnosis, Differential Doxorubicin / administration & dosage Etoposide / administration & dosage Eye Neoplasms / drug therapy, pathology, radiography Fatal Outcome Humans Hydrocortisone / blood Hyperkalemia / etiology Ifosfamide / administration & dosage L-Lactate Dehydrogenase / blood Lymphoma, T-Cell / blood, complications*, diagnosis, drug therapy, pathology Male Methotrexate / administration & dosage Neoplasm Proteins / blood Oculomotor Muscles / pathology, radiography Prednisone / administration & dosage Tomography, X-Ray Computed Tuberculosis, Endocrine / diagnosis Tumor Markers, Biological / blood Vincristine / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/CHOP protocol; 0/Neoplasm Proteins; 0/Tumor Markers, Biological; 16960-16-0/Cosyntropin; 23214-92-8/Doxorubicin; 33419-42-0/Etoposide; 3778-73-2/Ifosfamide; 50-02-2/Dexamethasone; 50-18-0/Cyclophosphamide; 50-23-7/Hydrocortisone; 53-03-2/Prednisone; 57-22-7/Vincristine; 59-05-2/Methotrexate; EC 1.1.1.27/L-Lactate Dehydrogenase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the t...
Next Document: Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell...